Contemporary Pediatrics, Digital Edition, June 2011
No needless pain : Managing pediatric pain in minor injuries
"Growing" pains : Apophysitis of the lower extremities
Dermcase : Multiple brown bumps in 9-month-old
Puzzler : The problem is not all in her head
Updates : Feds on Viral Hepatitis, Kwasaki disease, AAP on Pediatric Patient Safety, Secondhand smoke
Newsletter Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Subscribe
November 17th, 2026 The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
November 17th, 2026 The US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.
November 17th, 2026 At ACAAI 2026, 93.6% of pediatric biologic prescriptions needed prior authorization, 39.3% were denied, and approval took a mean of 33 days.
November 17th, 2026 US preterm birth rate held at 10.4%, earning a fifth straight D+ from March of Dimes; maternal deaths fell, but racial disparities persist.
November 16th, 2026 In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
November 16th, 2026 Data presented at NSGC 2026 tie maternal autoantibody combinations to a non-genetic autism subtype with high recurrence risk in later-born siblings.
November 16th, 2026 Caregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.
November 16th, 2026 Novo Nordisk filed etavopivat for SCD in patients aged 12+, backed by phase 3 HIBISCUS data showing a 27% drop in vaso-occlusive crises vs placebo.